The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s popular weight-loss drug Wegovy to treat a serious form of fatty liver disease.
This article was originally published on MedicalXpress.com
FDA approves Wegovy to treat serious liver disease
You may also be interested in:
The Latest
PetVet Dx Revolutionizes Wildlife Conservation with AI and Molecular Diagnostics to Combat Incurable CWD in Deer and Elk
Chronic wasting disease (CWD), a devastating prion illness that affects North American cervids like deer and elk, poses a grave threat to their well-being and conservation efforts. Furthermore, it presents a potential risk of human […]
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
The Latest
Why stress-related illness is so hard to diagnose, and how a patient-centred playful approach can help
For at least three decades, researchers have gathered evidence that chronic stress puts pressure on the body to constantly adjust itself to restore physiological stability. This process is known as allostatic load and it creates a cascade […]
Read More:
-
If it takes a village to raise a child, it also takes a village to care for children’s food needs.This article was originally published on [...]
-
Parents are spending thousands of pounds to bank stem cells from their children’s milk teeth—but the recipient companies’ claims about their future medical value are [...]
-
Young people who are offered confidential and free access to prescription contraception methods are significantly more likely to use them, according to a new McMaster [...]
